2024 Revisions of the McDonald Diagnostic Criteria: What Neurologists Need to Know
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
2024 Revisions of the McDonald Diagnostic Criteria: What Neurologists Need to Know
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
The 2024 Revisions of the McDonald Diagnostic Criteria for MS have been published in The Lancet Neurology. What do these changes mean for clinical practice?
In this episode, we are joined by two authors of the paper: Prof. Xavier Montalban, Chair of the International Advisory Committee on Clinical Trials in MS (IACCTMS), and Dr. Jiwon Oh of the University of Toronto. Together with host Brett Drummond of MStranslate, they discuss the significance of the updates, how these changes could expedite diagnosis and reduce misdiagnosis, and what they mean for the future of MS care globally.
Reference:
Montalban, X. et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. https://doi.org/10.1016/S1474-4422(25)00270-4 (2025).